Riehle Kimberly J, Vasudevan Sanjeev A, Bondoc Alexander, Cuenca Alex G, Garnier Hanna, Kastenberg Zachary, Roach Jonathan, Weldon Christopher B, Karpelowsky Jonathan, Hishiki Tomoro, Tiao Gregory
Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Pediatr Blood Cancer. 2025 Apr;72 Suppl 2:e31155. doi: 10.1002/pbc.31155. Epub 2024 Jul 2.
Two percent of pediatric malignancies arise primarily in the liver; roughly 60% of these cancers are hepatoblastoma (HB). Despite the rarity of these cases, international collaborative efforts have led to the consistent histological classification and staging systems, which facilitate ongoing clinical trials. Other primary liver malignancies seen in children include hepatocellular carcinoma (HCC) with or without underlying liver disease, fibrolamellar carcinoma (FLC), undifferentiated embryonal sarcoma of the liver (UESL), and hepatocellular neoplasm not otherwise specified (HCN-NOS). This review describes principles of surgical management of malignant pediatric primary liver tumors, within the context of comprehensive multidisciplinary care.
2%的儿童恶性肿瘤主要起源于肝脏;其中约60%为肝母细胞瘤(HB)。尽管这些病例罕见,但国际合作努力已形成了一致的组织学分类和分期系统,这有助于正在进行的临床试验。儿童中可见的其他原发性肝脏恶性肿瘤包括伴有或不伴有潜在肝脏疾病的肝细胞癌(HCC)、纤维板层癌(FLC)、肝脏未分化胚胎性肉瘤(UESL)以及未另行特指的肝细胞肿瘤(HCN-NOS)。本综述在全面多学科护理的背景下描述了儿童原发性肝脏恶性肿瘤的外科治疗原则。